InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Bencich John, Chairman & CEO. Officer active across 1 companies, notably Achieve Life Sciences, INC.. Aggregated, 5 disclosures have been logged. Total volume traded: €69k. The latest transaction was disclosed on 28 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
07,500 shares0
Common Stock
SEC:0001209191-22-026273:0·
068 shares0
Common Stock
SEC:0001209191-21-052578·
068 shares0
Common Stock
SEC:0001209191-21-052578:0·
€34,4456,000 shares@ €5.7409100.0% of flow
Common Stock
SEC:0001209191-21-036229·
Ideal exit: 21 Feb 2022 (T+270)
€34,4456,000 shares@ €5.74090.0063% mcap50.0% of flow
Common Stock
SEC:0001209191-21-036229:0·
Ideal exit: 21 Feb 2022 (T+270)
5 of 5 declarations
About Bencich John
John Bencich is the CEO of ACHIEVE LIFE SCIENCES, INC. He is responsible for the strategic and operational leadership of the company. With extensive experience in the life sciences sector, he plays a key role in product development and business expansion. His commitment to innovation and improving healthcare is essential for ACHIEVE's success.
